Category Archives: Cancer and neoplasms
SOUTH SAN FRANCISCO, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) — Harpoon Therapeutics, Inc. (Nasdaq: HARP), a clinical-stage immunotherapy company developing novel T cell engagers, today announced that it will host a live webcast at 8:00 a.m. ET / 2:00 p.m. CEST on Monday, October 23, 2023 to review interim monotherapy data from its Phase 1/2 clinical […]
Cancer and neoplasms
Development and validation of a prediction tool for intraoperative blood transfusion in brain tumor resection surgery: a retrospective analysis
Oct
Abstract Early identification of a patient with a high risk of blood transfusion during brain tumor resection surgery is difficult but critical for implementing preoperative blood-saving strategies. This study aims to develop and validate a machine learning prediction tool for intraoperative blood transfusion in brain tumor resection surgery. A total of 541 patients who underwent […]
Oct
Patients with myeloproliferative neoplasms (MPNs) — a group of blood cancers that causes the bone marrow to overproducer red or white blood cells or platelets (including polycythemia vera, essential thrombocythemia and myelofibrosis) — are at a particular risk for thrombotic and cardiovascular events. Kim Noonan, DNP, ANP-BC, AOCN, FAAN, Nursing and Patient Care Services Chief Nurse Practitioner […]
Oct
Bayer Unveils Latest Data from Oncology Portfolio at ESMO Congress 2023
Cancer and neoplasms
Assessing Yield, Harms, and Outcomes of Pancreatic Cancer Screening in At-Risk Individuals
Oct
The following is a summary of “Pancreatic Cancer Screening for At-Risk Individuals (Pancreas Scan Study): Yield, Harms, and Outcomes From a Prospective Multicenter Study,” published in the September 2023 issue of Gastroenterology by Shah, et al. Pancreatic cancer screening is recommended for individuals at high genetic risk, but the effectiveness and potential harms have not […]